Will this be the silver bullet to end with EMB as the gold-standard for post-HT monitoring? Results from the #SHORE registry show that the combination of GEP + dd-cfDNA is better associated with post-HT outcomes than EMB. Congrats all the authors for this amazing work #ishlt2024

Excited to share findings from the #DanGer trial #ACC24 from Jacob Moller CardioNerds #cardiogenicshock #ImpellaCS
🫀international, multicenter, randomized trial
🫀patients with STEMI and cardiogenic shock were assigned to Impella CP vs standard care only #NEJM

#CardiogenicShock in #Pregnancy warrants attention
🏷️⬆️ morbidity & mortality
🏷️ ⬇️ fetal outcomes
🏷️ Sparse data

Moderated by Dharini Ramu Jason N. Katz
Great talks by Natalie Tapaskar Jessica Schultz Anju Bhardwaj MD FACC Indranee Rajapreyar #RajivGulati #ACC24
Shelley Hall Katherine Clark Godiksen

🎇 StanfordCVFellowship representing at #ACC24 ! Krishna Pundi and Ramzi Dudum!

When you go way back! Emeka C. Anyanwu, MD Case Med Admissions MedChiefs #ACC24

💥Join us as we discuss specific considerations of managing #CardiogenicShock in pregnancy chaired by #CardioObs & #Shock experts Dharini Ramu Jason N. Katz

Looking forward for a great discussion Indranee Rajapreyar Natalie Tapaskar #RajivGulati #JessicaSchultz

#ValvularShock #ACC24

Amazing time at HoustonShock with some pretty awesome fellows and CardioNerds! #HSS24 . CardioNerds Amit Goyal MD MAS Daniel Ambinder, MD

Let's talk about risk scores in cardiogenic shock! Dr. Lansky Alexandra Lansky presents a fantastic talk at #HSS24 on available risk scores and their utility in cardiogenic shock. HoustonShock CardioNerds

⁦The importance to learn from all countries as discussed The Canadian experience by ⁦Filio Billia⁩ a lot to learn, excellent panel ⁦Joyce Wald⁩ ⁦Women in Heart Transplantation and MCS⁩ ⁦HoustonShock⁩

Incredible take away from Ayaaz K. Sachedina’s case of TAVR for refractory cardiogenic shock: “Survival and Success” rounds are just as important as Morbidity and Mortality rounds. 👏 HoustonShock #HSS24

Standing Room Only 👏! Day 2 of the Houston Shock Symposium! It’s not too late to join us at the Royal Sonesta to learn all things SHOCK! Free registration on-site!
#HSS24
Marwan Jumean, MD Alexander Hajduczok, MD 🇺🇦🙏 Patrick Zakka, MD Natalie Tapaskar Anju Bhardwaj MD FACC

Great way to kick off Day 2 at #HSS24 discussing the use of VA-ECMO in cardiogenic shock. Dr. Kapur Navin Kapur and Dr. Petr Ostadal share their expert opinions! Houston Shock Baseball CardioNerds

Great start to day 2 of HoustonShock with Navin Kapur highlighting the use of VA-ECMO in CS. #HSS24
🔑the use of ecmo in RCTs doesn’t match clinical practice
🔑we can’t ignore the brain. VAV better than ec-pella?
🔑role of proteins (e.g tafazzin) and medical management?

WYK,YK! Excellent presentation on acute tx of PAH crisis by Bindu Akkanti, MD. at #HSS2024 #HSS24
You don’t sit on critical AS or LMain disease , don’t sit on PAH!

Go big or go home!!
Fantastic talk by Kha Dinh discussing straight to #VVECMO in ARDS #HSS24 🫁

Fascinating talk by Marvin Slepian on patient perspectives on AI. Beware reverberation - repetitive misinformation! Lots of promise for AI to improve shock care. The 🔑is understanding the fundamentals. HoustonShock #HSS24 CardioNerds

Schrödinger's Shock! What’s the right therapy for the individual patient? Thanks Jason N. Katz for highlighting the 5-year horizon for CS. HoustonShock CardioNerds #HSS24 Patrick Zakka, MD
❓steroids in CS
❓IV vs PO anti-platelets
❓Impella CP: STEMI-CS
❓early IABP: ADHF-CS

Is the future of cardiogenic shock research in precision medicine? Proteomics? All the -omics? Thanks Marwan Jumean, MD for kicking off HoustonShock ! CardioNerds Patrick Zakka, MD #HSS2024